EUVIMEDEUVIMED entdecken
Crossref

Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms

Saurav Chopra iD, Nathanael G Bailey iD

American Journal of Clinical Pathology · 2023

DOI: 10.1093/ajcp/aqad097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Saurav Chopra und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, UPMC, Pittsburgh, PA, US. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Myelodysplastic Syndromes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Two new classifications of myeloid neoplasms have recently been published: the International Consensus Classification (ICC) and the 5th edition of the World Health Organization classification (WHO5). We sought to examine the real-world impact of dueling classifications on patient diagnoses.

Methods

Our institutional pathology database was searched, and 237 specimens with a diagnosis of myeloid neoplasia were randomly selected. For each case, a classification based on the WHO5 and the ICC was assigned. The WHO5 and ICC diagnoses were compared to determine their degree of concordance.

Results

After applying the WHO5 and ICC diagnostic criteria, 134 (56.5%) cases were classified as concordant, 63 (26.6%) cases had terminological differences, 37 (15.6%) cases had minor diagnostic discrepancies, and 3 (1.3%) cases had major diagnostic discrepancies. Cases with minor diagnostic discrepancies included 25 cases of myelodysplastic syndrome (MDS), 10 cases of acute myeloid leukemia (AML), and 2 cases of myeloid precursor lesions. Cases with major diagnostic discrepancies included 2 cases that were diagnosed as MDS, not otherwise specified (NOS), according to the ICC but classified as AML with NPM1 alteration and AML with RBM15::MRTFA according to the WHO5 and 1 case that was characterized as chronic myelomonocytic leukemia according to the ICC and as AML with NPM1 alteration according to the WHO5.

Conclusions

This study confirms that a majority of cases are classified similarly using the 2 systems. Given the overall similarity of the systems, future harmonization of the classifications should be pursued to avoid confusion and multiple diagnoses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myeloproliferative DisordersLeukemia, Myeloid, AcuteMyelodysplastic SyndromesHumansConsensusWorld Health OrganizationNuclear Proteins

Stichwörter der Autor:innen

International Consensus ClassificationWHOdiagnostic criteriamyeloid neoplasms

Substanzen

Nuclear Proteins

Autor:innen und Institutionen

  • Department of Pathology, UPMC, Pittsburgh, PA, US.
  • University of Pittsburgh, Pittsburgh PA.

ORCID-Profile: Saurav Chopra, Nathanael G Bailey

Zitieren

APA

Chopra, S., & Bailey, N. G. (2023). Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad097

Vancouver

Chopra S, Bailey NG. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad097

BibTeX
@article{Chopra2023,
  author = {Chopra, Saurav and Bailey, Nathanael G},
  title = {Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  doi = {10.1093/ajcp/aqad097}
}
Kostenlos starten →